Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: Combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1

Thorax

Volumn 55, Issue 2, 2000, Pages 121-125

  Yim, Jae Joon ^a   Park, Gye Young ^a   Lee, Choon Taek ^a   Kim, Young Whan ^a   Han, Sung Koo ^a   Shim, Young Soo ^a   Yoo, Chul Gyu ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Chronic obstructive pulmonary disease; Genetics; Glutathione S transferase; Microsomal epoxide hydrolase

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; EPOXIDE HYDROLASES; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; KOREA; LUNG DISEASES, OBSTRUCTIVE; MALE; MICROSOMES; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SMOKING; VITAL CAPACITY;

EID: 0034011463     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.2.121     Document Type: Article

References (27)

1. Mortality patterns: Preliminary data, United States, 1996. MMWR 1997;46:941-8.
2. Bascom R. Differential susceptibility to tobacco smoke: Possible mechanisms. Pharmacogenetics 1991;1:102-6.
3. 1 antitrypsin deficiency in nonsmokers. Am Rev Respir Dis 1978;117:421-8.
4. 1 antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294: 1316-21.
5. 1 antitrypsin deficiency. J Pediatr 1978;92:1006-10.
6. 1 antichymotrypsin deficiency. Acta Med Scand 1986;220:447-53.
7. Kauffman F, Kleisbauer J-P, Cambon-de-Mouzon A, et al. Genetic markers in chronic airflow limitation: A genetic epidemiologic study. Am Rev Respir Dis 1983;127:263-9.
8. Beatty TH, Menker HA, Cohen BH, et al. Risk factors associated with longitudinal change in pulmonary function. Am Rev Respir Dis 1984;129:660-7.
9. Watabe T, Kanai M, Isobe M, et al. The hepatic biotransformation of delta 5 steroids to 5 alpha, 6 beta-glycols via alpha- and beta-epoxides. J Biol Chem 1981;256:2900-7.
10. Hasset C, Aicher L, Sidhu JS, et al. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Human Mol Genet 1994;3:421-8.
11. Smith CAD, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997;350:630-3.
12. Ketterer B, Meyer DJ, Clark AG. Soluble glutathione transferase isoenzymes. In: Sies H, Ketterer B, eds. Glutathione Conjugation. London: Academic Press, 1988: 357-86.
13. Seidegard J, Pero RW, Miller DG, et al. A glutathione S-transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986;7:751-3.
14. Nazar-Stewart V, Motulsky AG, Eaton DL, et al. The glutathione S transferase μ polymorphism as a marker for the susceptibility to lung carcinoma. Cancer Res 1993;53: 2313-8.
15. Hirvonen A, Husgafvel-Pursianen K, Anttila S, et al. The GST M1 null genotypes as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993;14:1479-81.
16. Bell DA, Taylor JA, Paulson DF, et al. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
17. Fryer AA, Zhao CL, Alldersea J, et al. The glutathione S-transferases: Polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenoma. Carcinogenesis 1993;14:563-6.
18. Harrison DJ, Cantlay AM, Rae F, et al. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997;16: 356-60.
19. Pemble S, Schroeder KR, Spence SR, et al. Human glutathione S-transferase theta: cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300: 271-6.
20. Chenevix-Trench G, Young J, Coggan M, et al. Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility to colon cancer and age of onset. Carcinogenesis 1995;16: 1655-7.
21. Chen H, Sandler DP, Tayor JA, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta1 gene defect. Lancet 1996;347:295-7.
22. Elexpuru J, Buxton N, Kandula V, et al. Susceptibility to astrocytoma and meningioma: Influence of alleism at glutathione S-transferase (GST T1, GST M1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 1995;55: 4237-9.
23. Cantlay AM, Smith CAD, WAllace WA, et al. Heterogenous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax 1994;49:1010-4.
24. Buist AS, Vollmer WM, Wu Y, et al. Effects of cigarette smoking on lung function in four population samples in the People's Republic of China. The PRC-US Cardiovascular and Cardiopulmonary Epidemiology Research Group. Am J Respir Crit Care Med 1995;151:1393-400.
25. Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995;16:1243-5.
26. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996;6:187-91.
27. Ministry of Health and Welfare. Deaths by causes. In: Yearbook of Health and Welfare Statistics. Seoul: Ministry of Health and Welfare, 1998: 50-84.